Clinical applications of PET amyloid imaging: An update

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 7, 2009, Pages 1185-1190

  Lucignani, Giovanni ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 [6 [[2 FLUOROETHYL(METHYL)AMINO] 2 NAPHTHYL]ETHYLIDENE]MALONINITRILE F 18; 2 [4' (METHYLAMINO)PHENYL] 6 HYDROXYBENZOTHIAZOLE C 11; 2 [4' (METHYLAMINO)PHENYL] 6 HYDROXYBENZOTHIAZOLE H 3; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BENZOTHIAZOLE DERIVATIVE; CARBON 11; FLUORINE 18; NITRILE; PRESENILIN 1; RADIOPHARMACEUTICAL AGENT; TRITIUM; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; BINDING SITE; BRAIN; BRAIN MAPPING; CLINICAL DEMENTIA RATING SCALE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG UPTAKE; EARLY DIAGNOSIS; GENETIC RISK; HUMAN; ISOTOPE LABELING; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRESENILE DEMENTIA; PSYCHOLOGICAL RATING SCALE; REVIEW; SPASTIC PARESIS; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID; BENZOTHIAZOLES; COGNITION DISORDERS; HUMANS; NITRILES; POSITRON-EMISSION TOMOGRAPHY;

EID: 67349261429     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1148-3     Document Type: Review

References (17)

1. VL Villemagne MT Fodero-Tavoletti KE Pike R Cappai CL Masters CC Rowe 2008 The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias Mol Neurobiol 38 1 1 15
2. GW Small P Siddarth AC Burggren V Kepe LM Ercoli KJ Miller 2009 Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia Arch Gen Psychiatry 66 1 81 87
3. Braskie MN, Klunder AD, Hayashi KM, Protas H, Kepe V, Miller KJ, et al. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol Aging. 2008 Nov 10. [Epub ahead of print]. doi: 10.1016/j. neurobiolaging.2008.09.012.
4. http://www.loni.ucla.edu/approximatelythompson/FDDNP/video.html.
5. Grimmer T, Henriksen G, Wester HJ, Förstl H, Klunk WE, Mathis CA, et al. Clinical severity of Alzheimer's disease is associated with PIB uptake in PET. Neurobiol Aging. 2008 Mar 16. [Epub ahead of print] doi: 10.1016/j.neurobiolaging.2008.01.016.
6. J Fripp P Bourgeat O Acosta P Raniga M Modat KE Pike 2008 Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging Neuroimage 43 3 430 439
7. A Forsberg H Engler O Almkvist G Blomquist G Hagman A Wall 2008 PET imaging of amyloid deposition in patients with mild cognitive impairment Neurobiol Aging 29 10 1456 1465
8. HJ Aizenstein RD Nebes JA Saxton JC Price CA Mathis ND Tsopelas 2008 Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 11 1509 1517
9. CR Jack Jr VJ Lowe ML Senjem SD Weigand BJ Kemp MM Shiung 2008 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain 131 Pt 3 665 680 (Pubitemid 351294719)
10. L Ye A Velasco G Fraser TG Beach L Sue T Osredkar 2008 In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain J Neurochem 105 4 1428 1437 (Pubitemid 351590802)
11. SN Gomperts DM Rentz E Moran JA Becker JJ Locascio WE Klunk 2008 Imaging amyloid deposition in Lewy body diseases Neurology 71 12 903 910
12. P Edison CC Rowe JO Rinne S Ng I Ahmed N Kemppainen 2008 Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography J Neurol Neurosurg Psychiatry 79 12 1331 1338
13. W Maetzler I Liepelt M Reimold G Reischl C Solbach C Becker 2009 Cortical PIB binding in Lewy body dis ase is associated with Alzheimer-like characteristics Neurobiol Dis 34 1 107 112
14. J Koivunen A Verkkoniemi S Aalto A Paetau JP Ahonen M Viitanen 2008 PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease Brain 131 Pt 7 1845 1853 (Pubitemid 351957460)
15. AM Remes L Laru H Tuominen S Aalto N Kemppainen H Mononen 2008 Carbon 11-labeled Pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication Arch Neurol 65 4 540 544 (Pubitemid 351549966)
16. N Tolboom M Yaqub WM van der Flier R Boellaard G Luurtsema AD Windhorst 2009 Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET J Nucl Med 50 2 191 197
17. J Shin SY Lee SH Kim YB Kim SJ Cho 2008 Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease Neuroimage 43 2 236 244